Literature DB >> 9794849

Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.

K Featherstone1, J L Donovan.   

Abstract

OBJECTIVES: To explore trial participants' understandings of randomisation.
DESIGN: In this exploratory study, which used qualitative research methods, in-depth, semistructured interviews were carried out with 20 participants from the CLasP randomised controlled trial. Interviews were recorded on audio tape and fully transcribed. Data were analysed by comparing transcripts and describing emergent themes, using a grounded theory approach.
SETTING: The CLasP study comprises three linked multicentre, pragmatic randomised controlled trials evaluating the effectiveness and cost effectiveness of laser therapy, standard surgery, and conservative management for men with lower urinary tract symptoms or urinary retention, or both, related to benign prostatic disease.
SUBJECTS: 20 participants in the CLasP study were interviewed. Sampling was purposeful: men were included from each of the treatment arms, the two major centres, and at different points in the trial. INTERVENTIONS AND OUTCOME MEASURES: Interviews used a checklist of topics to encourage participants to describe their experiences. Narratives concerning randomisation were compared to identify common themes, retaining the context of the discussion to allow detailed interpretation.
RESULTS: Most participants recalled and described aspects of randomisation, such as the involvement of chance, comparison, and concealed allocation. Many found the concept of randomisation difficult, however, and developed alternative lay explanations to make sense of their experiences. Inaccurate patient information and lay interpretations of common trial terms caused confusion.
CONCLUSIONS: The provision of clear and accurate patient information is important, but this alone will not ensure consistent interpretation of concepts such as randomisation. Patients may need to discuss the purposes of randomisation in order to understand them fully enough to give truly informed consent.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  1998        PMID: 9794849      PMCID: PMC28698          DOI: 10.1136/bmj.317.7167.1177

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research.

Authors:  C Pope; N Mays
Journal:  BMJ       Date:  1995-07-01

2.  Incorporating patients' preferences into medical decisions.

Authors:  J P Kassirer
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

3.  Patients' preferences and randomised trials.

Authors:  W A Silverman; D G Altman
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

4.  Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

Authors:  H A Llewellyn-Thomas; M J McGreal; E C Thiel; S Fine; C Erlichman
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

5.  Patients' attitudes to participation in clinical trials.

Authors:  E G Bevan; L C Chee; S M McGhee; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

6.  Perceptions of cancer patients and their physicians involved in phase I trials.

Authors:  C Daugherty; M J Ratain; E Grochowski; C Stocking; E Kodish; R Mick; M Siegler
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

7.  Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium.

Authors:  B K Rimer; J M Schildkraut; C Lerman; T H Lin; J Audrain
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

8.  Clinical trial participation. Viewpoints from racial/ethnic groups.

Authors:  N L Roberson
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

9.  Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working Group.

Authors:  M J Henzlova; G H Blackburn; E J Bradley; W J Rogers
Journal:  Control Clin Trials       Date:  1994-08

10.  Volunteers or victims: patients' views of randomised cancer clinical trials.

Authors:  M Slevin; J Mossman; A Bowling; R Leonard; W Steward; P Harper; M McIllmurray; N Thatcher
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

View more
  85 in total

1.  Patients' understanding of randomised controlled trials depends on their education.

Authors:  E Pucci; N Belardinelli; M Signorino; F Angeleri
Journal:  BMJ       Date:  1999-03-27

2.  What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers.

Authors:  Christopher Bartlett; Jonathan Sterne; Matthias Egger
Journal:  BMJ       Date:  2002-07-13

3.  "Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.

Authors:  P A Newman; S Yim; A Daley; R Walisser; R Halpenny; W Cunningham; M Loutfy
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

4.  Scientific tools, fake treatments, or triggers for psychological healing: how clinical trial participants conceptualise placebos.

Authors:  Felicity L Bishop; Eric E Jacobson; Jessica R Shaw; Ted J Kaptchuk
Journal:  Soc Sci Med       Date:  2012-01-18       Impact factor: 4.634

5.  Training community health workers about cancer clinical trials.

Authors:  Lidia Schapira; Russell Schutt
Journal:  J Immigr Minor Health       Date:  2011-10

Review 6.  Just another drug? A philosophical assessment of randomised controlled studies on intercessory prayer.

Authors:  D D Turner
Journal:  J Med Ethics       Date:  2006-08       Impact factor: 2.903

Review 7.  Randomized controlled trials in endourology: a quality assessment.

Authors:  Jung Ki Jo; Riccardo Autorino; Jae Hoon Chung; Kyu Shik Kim; Jeong Woo Lee; Eun Jung Baek; Seung Wook Lee
Journal:  J Endourol       Date:  2013-07-26       Impact factor: 2.942

8.  Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations.

Authors:  Ricardo J Wray; Jo Ellen Stryker; Eric Winer; George Demetri; Karen M Emmons
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

9.  Participating in the United Kingdom Prospective Diabetes Study (UKPDS): a qualitative study of patients' experiences.

Authors:  Julia Lawton; Anna Fox; Charles Fox; Ann Louise Kinmonth
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

10.  Patients' perception of the informed consent process for neurooncology clinical trials.

Authors:  Eva Knifed; Nir Lipsman; Warren Mason; Mark Bernstein
Journal:  Neuro Oncol       Date:  2008-04-03       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.